Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Covid-19 crawled time : 10:00 save search
Global Self Testing Market Analysis Report 2023-2028: Breakdown by Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, & COVID-19 Testing
Published: 2023-11-08 (Crawled : 10:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.4%
H: 0.32%
C: -0.66%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.04%
H: 0.54%
C: -0.5%
QDEL | News M | $39.09 2.17% 2.12% 1.1M
|
Health Technology
|
| O: -0.15%
H: 1.46%
C: -1.98%
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: 1.04%
H: 6.04%
C: 1.81%
covid-19 pregnancy report urine cholesterol blood global market
Global COVID-19 Testing Markets Report 2023-2027 Featuring To 10 Vendors - Abbott, bioMerieux, Danaher, Hologic, PerkinElmer, Qiagen, QuidelOrtho, Roche, Siemens, ThermoFisher
Published: 2023-06-28 (Crawled : 10:00) - prnewswire.com
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.18%
H: 0.31%
C: -0.16%
DHR | $235.51 -0.36% 0.0% 2.3M
|
Health Technology
|
| O: -0.13%
H: 0.79%
C: 0.55%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -0.18%
H: 0.31%
C: -0.16%
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: -0.2%
H: 0.0%
C: -1.19%
covid-19 report global
United States Influenza Vaccines Market Analysis Report 2023: COVID-19/Influenza Combination Vaccines Gaining Momentum with GSK, CureVac and Novavax's Continued Advancements
Published: 2023-04-20 (Crawled : 10:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
covid-19 report momentum influenza market
European Medicines Agency Accepts Moderna's Conditional Marketing Authorization Filing for its Omicron BA.4/BA.5 Targeting Bivalent COVID-19 Vaccine
Published: 2022-09-28 (Crawled : 10:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 1.1%
H: 2.19%
C: -1.16%
covid-19 vaccine authorization
Global Vehicle Electrification Market Analysis Report 2022: Opportunities, Regulatory Scenario, Industry Trends, Merger and Acquisitions, New System Launch/Approvals, Impact of COVID-19 Pandemic
Published: 2022-09-13 (Crawled : 10:00) - prnewswire.com
DNZOY | $18.47 0.08% 47K
|
Manufacturing
|
| O: -0.31%
H: 0.0%
C: -2.18%
KT | $12.2 0.25% 0.0% 340K
|
Communications
|
| O: -1.56%
H: 0.23%
C: -1.59%
BWA | $32.8 2.15% 0.0% 2.2M
|
Producer Manufacturing
|
| O: -3.04%
H: 1.26%
C: -0.76%
covid-19 global system report impact market
Global Ginseng Market Research Report 2022: The Potential Role of Ginseng in Influenza and COVID-19 Management
Published: 2022-08-25 (Crawled : 10:00) - prnewswire.com
CLZNF | $12.8886 68.54% 3.6K
|
Process Industries
| Email alert
Add to watchlist
CLZNY | $14.76 27.55% 310
|
Manufacturing
| Email alert
Add to watchlist
covid-19 management research global report potential influenza market
Global Anesthesia and Respiratory Devices Market Report 2022-2027: Overview, Patent Review/New Developments, Pipeline Analysis, COVID-19 Impacts, Competitive Landscape
Published: 2022-08-17 (Crawled : 10:00) - prnewswire.com
RMD | $178.85 0.7% 0.0% 1.2M
|
Health Technology
|
| O: -0.45%
H: 0.73%
C: 0.59%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.8%
H: 0.75%
C: 0.38%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.36%
H: 0.45%
C: -0.97%
covid-19 patent global report respiratory market
Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Declined Emergency Use Authorization for Aviptadil for a Subgroup of Patients with Critical COVID-19 at Immediate Risk
Published: 2022-07-04 (Crawled : 10:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
| Email alert
Add to watchlist
RLFTY | $1.4006 733.33% 100
|
n/a
| Email alert
Add to watchlist
NRXP 2 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
| Email alert
Add to watchlist
covid-19 fda risk collaboration aviptadil authorization emergency use authorization
Bavarian Nordic Provides Update on the Phase 3 Program for its COVID-19 Booster Vaccine Candidate
Published: 2022-06-16 (Crawled : 10:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
covid-19 vaccine program update phase 3
Microgrid Market Size, Growth Projections to 2028 Strategic Developments, Covid-19 Impact, Global Analysis and Forecasts by The Insight Partners
Published: 2022-06-13 (Crawled : 10:00) - prnewswire.com
HON | News M | $194.27 1.67% 1.64% 3.6M
|
Producer Manufacturing
|
| O: -3.15%
H: 0.0%
C: 0.0%
EXC 4 | $37.58 2.45% 2.39% 6.1M
|
Utilities
|
| O: -1.84%
H: 0.4%
C: -3.49%
covid-19 growth market
Global At-Home Diagnostic Testing Markets, 2019-2021 & 2021-2026: Glucose, COVID-19, HIV, Other Infections, Cholesterol, Drug of Abuse, Coagulation, FOB, Pregnancy & Fertility
Published: 2022-05-09 (Crawled : 10:00) - prnewswire.com
QDEL | News M | $39.09 2.17% 2.12% 1.1M
|
Health Technology
|
| O: -6.19%
H: 1.23%
C: -4.94%
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: -1.34%
H: 3.21%
C: -4.57%
DXCM | $130.71 -2.67% -2.75% 2.8M
|
Health Technology
|
| O: -7.77%
H: 1.69%
C: -3.72%
covid-19 pregnancy drug diagnostic infections hiv
Global TDI & MDI Market Key Players, Covid-19 Impact Analysis, Growth and Size to Reach US$7.96 billion in 2026 - ReportsnReports
Published: 2022-03-28 (Crawled : 10:00) - prnewswire.com
HUN | $23.72 0.0% 1.6M
|
Process Industries
|
| O: -2.73%
H: 3.74%
C: 3.3%
DD | News | $73.89 0.49% 0.0% 2.3M
|
Process Industries
|
| O: -0.82%
H: 0.18%
C: -0.16%
covid-19 growth market
Global Fast Food Market Size Worth $998 Billion, Globally, by 2028 at 4.6% CAGR,(Including COVID-19 Impact Analysis): Exclusive Report by Zion Market Research
Published: 2022-03-03 (Crawled : 10:00) - prnewswire.com
QSR | $71.42 0.08% 0.0% 930K
|
Consumer Services
|
| O: 1.25%
H: 0.0%
C: 0.0%
BOX 4 | $26.67 0.76% -0.0% 1.5M
|
Technology Services
|
| O: 8.53%
H: 0.11%
C: -5.18%
JACK | $59.62 2.51% 2.45% 660K
|
Consumer Services
|
| O: 0.21%
H: 0.26%
C: -1.87%
covid-19 research covid food report
QIAGEN Completes U.S. Federal Contract to Equip Local Public Health Authorities with QIAcuity Digital PCR System for COVID-19 Surveillance
Published: 2022-01-25 (Crawled : 10:00) - biospace.com/
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -1.58%
H: 0.62%
C: -0.52%
QGEN | $40.0 1.34% 0.0% 1.1M
|
Health Technology
|
| O: -1.58%
H: 0.62%
C: -0.52%
covid-19 health contract system covid
Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who've Exhausted All Approved Therapies
Published: 2022-01-19 (Crawled : 10:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: 1.51%
H: 3.09%
C: -1.37%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -6.53%
H: 3.29%
C: 3.29%
covid-19 aviptadil expansion program respiratory covid report collaboration
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001
Published: 2022-01-06 (Crawled : 10:00) - biospace.com/
DVAX | $11.78 3.88% 3.74% 9.3M
|
Health Technology
|
| O: 4.52%
H: 7.13%
C: -0.53%
covid-19 valneva trial covid vla200 vaccine vla2001 submission
Positive Covid-19 Test
Published: 2022-01-05 (Crawled : 10:00) - taylordevices.com
TAYD A | $47.53 1.93% 1.89% 16K
|
Producer Manufacturing
| Email alert
Add to watchlist
covid-19 covid test positive
NRx Pharmaceuticals Submits Emergency Use Authorization Application to US FDA for ZYESAMI® (aviptadil) to Treat Patients at Immediate Risk of Death from COVID-19 Despite Treatment with Remdesivir and Other Approved Therapies
Published: 2022-01-05 (Crawled : 10:00) - biospace.com/
NRXP 2 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: 1.52%
H: 0.0%
C: 0.0%
covid-19 zyesami treatment fda aviptadil als risk application covid media authorization merge emergency use authorization
Relief Reports US Collab. Partner Announces Submission to FDA seeking EUA for Aviptadil for Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies
Published: 2022-01-06 (Crawled : 10:00) - biospace.com/
RLFTF | $1.43 11.45% 3.8K
|
n/a
|
| O: 19.47%
H: 3.85%
C: -11.85%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: 2.87%
H: 0.0%
C: 0.0%
NRXP 2 d | $3.08 1.99% 1.95% 230K
|
Manufacturing
|
| O: -3.39%
H: 6.19%
C: 3.92%
covid-19 treatment fda aviptadil risk covid media submission
Could a Common Antidepressant Help Against COVID-19?
Published: 2021-12-13 (Crawled : 10:00) - brainsway.com
BWAY | $4.835 0.94% 0.93% 41K
|
Health Technology
|
| O: 4.3%
H: 0.0%
C: 0.0%
covid-19 covid
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.